| 000 | 01841 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513185030.0 | ||
| 264 | 0 | _c19990811 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/ajrccm.160.1.9810082 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSnyder, D C | |
| 245 | 0 | 0 |
_aTuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cJul 1999 |
||
| 300 |
_a178-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xeconomics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHIV Seropositivity _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xeconomics |
| 650 | 0 | 4 |
_aMethadone _xeconomics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyridoxine _xadministration & dosage |
| 650 | 0 | 4 | _aSan Francisco |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xeconomics |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculin Test _xeconomics |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xeconomics |
| 650 | 0 | 4 |
_aUrban Population _xstatistics & numerical data |
| 700 | 1 | _aPaz, E A | |
| 700 | 1 | _aMohle-Boetani, J C | |
| 700 | 1 | _aFallstad, R | |
| 700 | 1 | _aBlack, R L | |
| 700 | 1 | _aChin, D P | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 160 _gno. 1 _gp. 178-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/ajrccm.160.1.9810082 _zAvailable from publisher's website |
| 999 |
_c10348732 _d10348732 |
||